PREVENTION OF COVID-19 INFECTION WITH POVIDONE-IODINE
MD, PhD Luis Mendoza, Sr Medical, Advisor Medical, Scientific Services
In late 2019, a novel coronavirus, SARS-CoV-2, which causes Coronavirus disease 2019 (COVID-19), appeared in Wuhan, China. On January 30, 2020, the World Health Organization (WHO) declared the current outbreak of COVID-19 to be a public health emergency of international concern. There is no treatment for COVID-19 infection besides preventive measures recommended by the WHO. Povidone-iodine (PVP-I) is an antiseptic that has primarily been used for the prevention or management of wound infections for over 150 years. Its antibacterial, antiviral, and antifungal properties and its safety have been welldocumented. This article reviews the studies that have assessed the antiviral efficacy of PVP-I and its potential use as a prophylactic on the oropharyngeal and nasopharyngeal mucosa of healthcare workers, COVID-19 patients, and the community as an additional measure to help abate the pandemic.
References
Altman, Bland, Stataistics notes: Absence of evidence is not evidence of absence, BMJ
Amsley, Metcalf, Effect of povidone-iodine on herpesvirus type 2, in vitro, Obstet Gynecol
Bigliardi, Alsagoff, El-Kafrawi, Povidone iodine in wound healing: A review of current concepts and practices, Int J Surg
Durani, Leaper, Povidone-iodine: use in hand disinfection, skin preparation and antiseptic irrigation, Int Wound J
Eggers, Eickmann, Kowalski, Povidone-iodine hand wash and hand rub products demonstrated excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses, BMC Infect Dis
Eggers, Eickmann, Zorn, Rapid and effective virucidal activity of povidone-iodine products against Middle East respiratory syndrome coronavirus (MERS-CoV) and modified vaccinia virus ankara (MVA), Infect Dis Ther
He, Lau, Wu, Temporal dynamics in viral shedding and transmissibility of COVID-19, Nat Med
Ito, Ito, Hikida, Outbreak of highly pathogenic avian influenza in Japan and anti-influenza virus activity of povidone-iodine products, Dermatology
Kampf, Todt, Pfaendr, Steinmann, Persistence of coronavirus on inanimate surfaces and their inactivation with biocidal agents, Journal of Hospital Infection
Kariwa, Fujii, Takashima, Inactivation of SARS coronavirus by means of povidoneiodine, physical conditions, and chemical reagents, Dermatology
Kawana, Kitamura, Nakagomi, Inactivation of human viruses by povidoneiodine in comparison with other antiseptics, Dermatology
Kirk-Bayley, Combes, Sunkaraneni, Vishnu, Challacombe, The Use of Povidone Iodine Nasal Spray and Mouthwash During the Current COVID-19 Pandemic May Reduce Cross Infection and Protect Healthcare Workers
Kitamura, Satomura, Kowamura, Can we prevent-influenza-like illnesses by gargling, Internal Medicine
Lescure, Bouadma, Nguyen, Clinical and virological data of the first cases of COVID-19 in Europe a case series, The Lancet Infectious Diseases
Matthews, Beyond significance: principles and practice of the Analysis of Credibility, Royal Society Open Science
Wewalka, Stary, Bosse, Duerr, Reimer, Efficacy of povidone-iodine vaginal suppositories in the treatment of bacterial vaginosis, Dermatology
Zou, Ruan, Huang, SARS-CoV-2 viral load in upper respiratory specimens of infected patients, N Engl J Med
